BIC
BIIB icon

Bridges Investment Counsel’s Biogen BIIB Stock Holding History

Bridges Investment Counsel’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		$629K Sell
1,975
-400
-17% -$128K 0.35% 73
2017
Q3 		$744K Sell
2,375
-5,397
-69% -$1.6M 0.41% 65
2017
Q2 		$2.11M Buy
7,772
+3,190
+70% +$844K 0.48% 63
2017
Q1 		$1.25M Sell
4,582
-3,525
-43% -$997K 0.37% 62
2016
Q4 		$2.3M Sell
8,107
-1,650
-17% -$489K 0.56% 57
2016
Q3 		$3.05M Buy
9,757
+75
+0.8% +$22.2K 0.64% 50
2016
Q2 		$2.34M Buy
9,682
+190
+2% +$50.1K 0.51% 61
2016
Q1 		$2.47M Sell
9,492
-2,273
-19% -$600K 0.53% 56
2015
Q4 		$4.75M Hold
11,765
– – 0.82% 33
2015
Q3 		$4.75M Buy
11,765
+5,628
+92% +$1.86M 0.82% 33
2015
Q2 		$2.48M Buy
6,137
+1,500
+32% +$602K 0.58% 53
2015
Q1 		$1.96M Buy
4,637
+300
+7% +$118K 0.45% 64
2014
Q4 		$1.47M Buy
4,337
+960
+28% +$311K 0.34% 81
2014
Q3 		$1.12M Hold
3,377
– – 0.26% 90
2014
Q2 		$1.06M Sell
3,377
-250
-7% -$75.2K 0.24% 94
2014
Q1 		$1.11M Hold
3,627
– – 0.26% 89
2013
Q4 		$1.01M Hold
3,627
– – 0.23% 94
2013
Q3 		$873K Buy
3,627
+875
+32% +$196K 0.22% 99
2013
Q2 		$592K Buy
+2,752
New +$588K 0.15% 110

Other funds holding BIIB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Bridges Investment Counsel's BIIB Position: Q4 2017 in Review

Bridges Investment Counsel reduced its Biogen (BIIB) stake by 17% in Q4 2017, selling an estimated $128K and leaving 1,975 shares worth $629K. The position accounts for 0.35% of the portfolio, ranked #73.

Bridges Investment Counsel first reported a position in BIIB in Q2 2013 and has held it in 19 quarters since. The position peaked at $4.75M in Q4 2015. 1,122 funds tracked by Wall St. Rank hold BIIB as of Q4 2017.

  • Bridges Investment Counsel held 1,975 shares of Biogen worth $629K as of Q4 2017.
  • Bridges Investment Counsel sold 400 Biogen shares in Q4 2017, an estimated $128K.
  • Biogen made up 0.35% of Bridges Investment Counsel's portfolio in Q4 2017, its #73 holding.
  • Bridges Investment Counsel first reported a position in Biogen in Q2 2013 and has held it in 19 quarters since.
  • Bridges Investment Counsel's Biogen position peaked at $4.75M in Q4 2015.
  • 1,122 funds tracked by Wall St. Rank held Biogen as of Q4 2017.

Based on Bridges Investment Counsel's 13F filing for Q4 2017, filed 9 Feb 2018.